Maxim Group Has Lowered Expectations for scPharmaceuticals (NASDAQ:SCPH) Stock Price
scPharmaceuticals (NASDAQ:SCPH – Get Free Report) had its target price dropped by investment analysts at Maxim Group from $20.00 to $12.00 in a report released on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Maxim Group’s price objective would suggest a potential upside of 300.00% from the company’s current price. Separately, […]
